This is the authors' abstract. We don't add key points for this paper.
Skeletal muscle regeneration is orchestrated by an interplay of several cell types. It is initiated by local inflammation triggered by the dying cells, and involves phagocytosis of dead cells at the site of injury. Efferocytosis regulates the inflammatory program in macrophages by initiating the conversion of their inflammatory phenotype into the reparative one. While pro-inflammatory cytokines produced by them induce satellite cell proliferation and differentiation into myoblasts, growth factors (GDF3 and IGF-1) released by the reparative macrophages drive myoblast fusion and myotube growth. IGF-1 is also produced by differentiating myoblasts. Adenosine is generated from ATP released by dead cells following tissue injury. It mediates its physiological effects via four types of adenosine receptors. Among these, adenosine A2 receptors (A2Rs) expressed by myoblasts and macrophages increase adenylate cyclase activity, A2ARs being activated by moderately increased, while A2BRs by high concentrations of adenosine. Here we report that A2AR ablation results in decreased muscle weights, generation of small-sized myofibers in fast-twitch Nur77-expressing muscles, and alterations in muscle force generation in A2AR −/− mice. Following cardiotoxin-induced injury, fewer inflammatory cells transmigrated to the injury site, the dead cell clearance and the conversion of Ly6C high inflammatory macrophages to Ly6C low Nur77 + GDF3 + and to Ly6C low Nur77 + MHCII high cells were delayed, the Igf1 and Gdf3 expressions decreased, myoblast fusion was impaired and the size of regenerating fibers was smaller in the tibialis anterior muscle of A2AR −/− mice. In contrast, stimulation of A2ARs facilitated myoblast fusion in differentiating C2C12 myoblasts by promoting their Igf1 expression, while administration of an A2BR agonist to promote A2R signaling following cardiotoxin-induced injury stimulated myofiber fusion and growth in wild-type mice in a Nur77-dependent manner. Our data indicate that A2Rs play a key role in determining the myofiber size during development and the response to tissue injury, consequently A2BR agonists could be used to facilitate skeletal muscle regeneration.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Szondy et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: